A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.

Suzannah J Rihn ORCID logo; Andres Merits; Siddharth Bakshi; Matthew L Turnbull ORCID logo; Arthur Wickenhagen ORCID logo; Akira JT Alexander ORCID logo; Carla Baillie; Benjamin Brennan ORCID logo; Fiona Brown; Kirstyn Brunker; +72 more... Steven R Bryden ORCID logo; Kerry A Burness; Stephen Carmichael; Sarah J Cole; Vanessa M Cowton; Paul Davies ORCID logo; Chris Davis; Giuditta De Lorenzo ORCID logo; Claire L Donald ORCID logo; Mark Dorward; James I Dunlop; Matthew Elliott; Mazigh Fares; Ana da Silva Filipe ORCID logo; Joseph R Freitas; Wilhelm Furnon ORCID logo; Rommel J Gestuveo ORCID logo; Anna Geyer; Daniel Giesel; Daniel M Goldfarb ORCID logo; Nicola Goodman ORCID logo; Rory Gunson; C James Hastie ORCID logo; Vanessa Herder ORCID logo; Joseph Hughes ORCID logo; Clare Johnson; Natasha Johnson ORCID logo; Alain Kohl; Karen Kerr; Hannah Leech ORCID logo; Laura Sandra Lello; Kathy Li; Gauthier Lieber ORCID logo; Xiang Liu; Rajendra Lingala; Colin Loney; Daniel Mair ORCID logo; Marion J McElwee; Steven McFarlane; Jenna Nichols ORCID logo; Kyriaki Nomikou ORCID logo; Anne Orr; Richard J Orton ORCID logo; Massimo Palmarini; Yasmin A Parr ORCID logo; Rute Maria Pinto ORCID logo; Samantha Raggett; Elaine Reid; David L Robertson ORCID logo; Jamie Royle ORCID logo; Natalia Cameron-Ruiz ORCID logo; James G Shepherd ORCID logo; Katherine Smollett ORCID logo; Douglas G Stewart; Meredith Stewart ORCID logo; Elena Sugrue ORCID logo; Agnieszka M Szemiel; Aislynn Taggart ORCID logo; Emma C Thomson ORCID logo; Lily Tong ORCID logo; Leah S Torrie; Rachel Toth; Margus Varjak; Sainan Wang; Stuart G Wilkinson ORCID logo; Paul G Wyatt; Eva Zusinaite; Dario R Alessi; Arvind H Patel ORCID logo; Ali Zaid ORCID logo; Sam J Wilson ORCID logo; Suresh Mahalingam ORCID logo; (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS biology, 19 (2). e3001091-. ISSN 1544-9173 DOI: 10.1371/journal.pbio.3001091
Copy

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/, constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science.


picture_as_pdf
journal.pbio.3001091.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads